Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase Ib trial of omadacycline in patients with uncomplicated urinary tract infection

Trial Profile

A phase Ib trial of omadacycline in patients with uncomplicated urinary tract infection

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2019

At a glance

  • Drugs Omadacycline (Primary) ; Omadacycline (Primary)
  • Indications Cystitis; Urinary tract infections
  • Focus Pharmacokinetics; Proof of concept
  • Most Recent Events

    • 11 Mar 2019 Results published in the Antimicrobial Agents and Chemotherapy
    • 24 May 2017 Data from this trial will be presented at the ASM Microbe 2017, according to a Paratek Pharmaceuticals media release.
    • 03 Apr 2017 According to a Paratek Pharmaceuticals media release, positive top-line PK proof-of-principle data was reported in November 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top